Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Equine infectious anemia

D C Sellon1

  • 1Department of Food Animal and Equine Medicine, North Carolina State University College of Veterinary Medicine, Raleigh.

The Veterinary Clinics of North America. Equine Practice
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AAEP/EVJ supplement 2013.

Equine veterinary journal. Supplement·2013
Same author

Hepatic abscesses in three horses.

Journal of the American Veterinary Medical Association·2012
Same author

A retrospective analysis of renal carcinoma in the horse.

Journal of veterinary internal medicine·2009
Same author

Pharmacokinetics of butorphanol in horses after intramuscular injection.

Journal of veterinary pharmacology and therapeutics·2009
Same author

Pharmacokinetics of butorphanol and evaluation of physiologic and behavioral effects after intravenous and intramuscular administration to neonatal foals.

Journal of veterinary internal medicine·2008
Same author

Ulcerative dermatitis, thrombocytopenia, and neutropenia in neonatal foals.

Journal of veterinary internal medicine·2005
Same journal

Pharmaceutical and Nutraceutical Therapies for Liver Disease.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Clinical Signs of Liver Disease in Horses.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Syndrome of High Gamma-Glutamyl Transferase in Racehorses.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Equine Hepatology in Practice: Insights, Challenges, and Progress.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Pathophysiology and Treatment of Hepatic Encephalopathy.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Viral Hepatitis.

The Veterinary clinics of North America. Equine practice·2026
See all related articles

Equine infectious anemia virus (EIAV) persistently infects horses by evading immune responses and changing its antigens, hindering vaccine development. Control requires cooperation due to widespread asymptomatic infections.

Area of Science:

  • Veterinary Immunology
  • Infectious Diseases
  • Equine Health

Background:

  • Equine infectious anemia virus (EIAV) causes a persistent infection in horses, posing a significant threat to the US horse population.
  • EIAV's ability to evade host immune defenses through latency and rapid antigenic variation presents major challenges for disease control and vaccine development.
  • The majority of EIAV-infected horses are clinically normal and untested, complicating eradication efforts and potentially leading to complacency in the horse industry.

Purpose of the Study:

  • To highlight the challenges posed by EIAV persistence and immune evasion in horses.
  • To underscore the difficulties in developing effective vaccines against EIAV.
  • To emphasize the need for continued vigilance and cooperation among stakeholders for EIAV control.

Main Methods:

Related Experiment Videos

  • The abstract does not detail specific experimental methods.
  • It relies on summarizing established knowledge regarding EIAV's pathogenesis and epidemiological characteristics.

Main Results:

  • EIAV establishes persistent infections by evading host immunity via dormancy and antigenic drift.
  • Vaccine development is significantly hindered by the virus's immune-evasive strategies.
  • Widespread asymptomatic infections make eradication unlikely and necessitate ongoing control measures.

Conclusions:

  • Effective control of Equine Infectious Anemia (EIA) requires a collaborative approach involving horse owners, veterinarians, and regulatory bodies.
  • The persistent and asymptomatic nature of EIAV infections demands sustained efforts to manage the disease threat in the United States.
  • Addressing EIAV necessitates ongoing research into its immune evasion mechanisms and improved diagnostic/control strategies.